Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Immunomedics, Inc. |
---|---|
Information provided by: | Immunomedics, Inc. |
ClinicalTrials.gov Identifier: | NCT00041652 |
The purpose of this trial is to determine the safety of hMN14 at different dose levels in the treatment of either colorectal or breast cancer.
Condition | Intervention | Phase |
---|---|---|
Colorectal Cancer Colon Cancer Rectal Cancer Colorectal Neoplasms Colorectal Carcinoma Breast Cancer Breast Neoplasms |
Drug: hMN14 (labetuzumab) |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Dose Comparison, Single Group Assignment, Safety Study |
Official Title: | A Phase I/II Clinical Trial of Immunotherapy With Humanized MN-14 IgG in Recurrent, Metastatic, Unresectable Colorectal and Breast Carcinomas |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Disease Characteristics:
Prior/Concurrent Therapy:
Patient Characteristics/Inclusion Criteria:
United States, California | |
Hoag Cancer Center | |
Newport Beach, California, United States, 92658 |
Study Director: | Terence Rugg, MD | Immunomedics, Inc. |
Study Chair: | Lauri Welles, MD | Immunomedics, Inc. |
Study ID Numbers: | IM-T-hMN14-04 |
Study First Received: | July 11, 2002 |
Last Updated: | October 21, 2005 |
ClinicalTrials.gov Identifier: | NCT00041652 |
Health Authority: | United States: Food and Drug Administration |
Colorectal Cancer Colon Cancer Rectal Cancer Colorectal Neoplasms |
Colorectal Carcinoma Breast Cancer Breast Neoplasms |
Digestive System Neoplasms Skin Diseases Gastrointestinal Diseases Rectal Neoplasms Colonic Diseases Breast Neoplasms Intestinal Diseases Rectal Diseases Recurrence Intestinal Neoplasms |
Rectal neoplasm Carcinoma Digestive System Diseases Gastrointestinal Neoplasms Rectal cancer Colonic Neoplasms Colorectal Neoplasms Breast Diseases Neoplasms, Glandular and Epithelial |
Neoplasms Neoplasms by Histologic Type Neoplasms by Site |